Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation
2021; Springer Science+Business Media; Volume: 41; Issue: 4 Linguagem: Inglês
10.1007/s10875-020-00943-y
ISSN1573-2592
AutoresBaşak Kayaoğlu, Nurhan Kasap, Naz Surucu Yilmaz, Louis‐Marie Charbonnier, Büsra Geckin, Arzu Akçay, Sevgi Bilgiç Eltan, Gülyüz Öztürk, Ahmet Özen, Elif Karakoç-Aydıner, Talal A. Chatila, Mayda Gürsel, Safa Barış,
Tópico(s)Hematopoietic Stem Cell Transplantation
Referência(s)